期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Retrospective Cohort Study of Preimplantation Genetic Testing for Aneuploidy with Comprehensive Chromosome Screening versus Nonpreimplantation Genetic Testing in Normal Karyotype,Secondary Infertility Patients with Recurrent Pregnancy Loss 被引量:5
1
作者 Cai-Xia Lei Jiang-Feng Ye +2 位作者 Yi-Lun Sui Yue-Ping Zhang Xiao-Xi Sun 《Reproductive and Developmental Medicine》 CSCD 2019年第4期205-212,共8页
Objective:To evaluate whether preimplantation genetic testing for aneuploidy(PGT-A)with comprehensive chromosome screening increases live birth rate(LBR)in normal karyotype couples with recurrent pregnancy loss(RPL).M... Objective:To evaluate whether preimplantation genetic testing for aneuploidy(PGT-A)with comprehensive chromosome screening increases live birth rate(LBR)in normal karyotype couples with recurrent pregnancy loss(RPL).Methods:A retrospective cohort follow-up study of 506 couples with RPL was conducted between April 2014 and March 2017.Couples were allocated to two groups according to their decision to choose PGT-A or not.The primary outcome was LBR per start/transfer cycle;secondary outcomes were ongoing pregnancy rate and miscarriage rate.Statistical analyses were conducted using univariate and multivariate logistic regression models adjusted for maternal age.Results:LBR per start(26.6%vs.15.4%,relative risk[RR]:2.66,95%confidence interval[CI][1.69-4.20],P<0.0001;adjusted RR[aRR]:2.40,95%CI[1.49-3.86],P=0.0004)and per transfer(44.9%vs.25.1%,RR:3.00,95%CI[1.96-4.60],P<0.0001;aRR:2.64,95%CI[1.68-4.14],P<0.0001)was significantly higher in the PGT-A group than in the non-PGT-A group.The miscarriage rate was significantly lower in the PGT-A group compared to the non-PGT-A group(15.7%vs.34.6%,RR:0.27,95%CI[0.13-0.57],P=0.00005;aRR:0.26,95%CI[0.12-0.57],P=0.0007).Conclusions:LBR per start cycle following PGT-A is significantly higher,and risk of miscarriage is significantly lower among infertile couples with RPL,irrespective of maternal age.PGT-A should be recommended to infertile couples with RPL. 展开更多
关键词 comprehensive chromosome screening Preimplantation Genetic Testing for Aneuploidy Recurrent Pregnancy Loss
原文传递
植入前遗传学诊断/筛查技术指征进展 被引量:8
2
作者 雷彩霞 张月萍 孙晓溪 《中华生殖与避孕杂志》 CAS CSCD 北大核心 2017年第3期235-239,共5页
植入前遗传学诊断/筛查(PGD/PGS)技术发展多年,其指征始终存在争议。PGD指征较为明确,单基因遗传病、染色体异常人群、人类白细胞抗原(HLA)配型为其适用人群。PGS的指征争议较多,主要面向反复流产、反复植入失败、高龄人群,目的是提高... 植入前遗传学诊断/筛查(PGD/PGS)技术发展多年,其指征始终存在争议。PGD指征较为明确,单基因遗传病、染色体异常人群、人类白细胞抗原(HLA)配型为其适用人群。PGS的指征争议较多,主要面向反复流产、反复植入失败、高龄人群,目的是提高妊娠率及活产率。然而第一代PGS技术[PGS#1,卵裂球活检及荧光原位杂交(FISH)-PGS]技术未显示明显效果,甚至降低了妊娠率及活产率。第二代PGS技术(PGS2.0)增加了严重男性因素不育为指征,其核心为囊胚活检及全染色体筛查(CCS),对上述人群的临床效果较为明显,降低了流产风险并提高了成功率及活产率。PGS2.0已极大地改变了辅助生殖技术(ART)面貌,可能成为未来生殖中心对所有患者的一个常规项目。目前仍然需要多中心前瞻性随机病例对照研究重新评估PGS。 展开更多
关键词 植入前遗传学诊断(PGD) 植入前遗传学筛查(PGs) 辅助生殖技术(ART) 荧光原位杂交(FISH) 全染色体筛查(ccs)
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部